U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H15N5O2.2ClH
Molecular Weight 286.159
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXDRALAZINE DIHYDROCHLORIDE

SMILES

Cl.Cl.NNC1=CC=C(N=N1)N(CCO)CCO

InChI

InChIKey=UKFTXWKNVSVVCJ-UHFFFAOYSA-N
InChI=1S/C8H15N5O2.2ClH/c9-10-7-1-2-8(12-11-7)13(3-5-14)4-6-15;;/h1-2,14-15H,3-6,9H2,(H,10,11);2*1H

HIDE SMILES / InChI
Oxdralazine is a peripheral vasodilator that was studied for patients with severe essential hypertension. The clinical trial has shown that at the end of the third month 25 patients on the triple regimen (chlorthalidone plus oxdralazine plus propranolol) achieved a stable diastolic blood pressure of 90 mm Hg or less. However, information about the further development of this drug is not available.

Approval Year

PubMed

PubMed

TitleDatePubMed
Disposition and metabolism of 3-hydrazino-6-[N,N-bis(2-hydroxyethyl)amino] pyridazine dihydrochloride in man.
1979
Long-term study of oxdralazine in hypertensive patients.
1979
Metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine dihydrochloride in rat urine.
1979
Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
1978-08
Antihypertensive and antidiuretic effects of 3-hydrazino-6-[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) in rats.
1978-06
Clinical and haemodynamic study of a new vasodilator drug L6150 (3-[bis-(2-hydroxyethyl)amino]-6-hydrazinopyridazine) in man.
1976-12
A comparative study of the hemodynamic effects of single intravenous doses of 3-hydrazino-6-[N,N-bis-(2-hydroxyethyl)-amino]-pyridazine-dihydrochloride and hydralazine.
1976
Systemic and coronary haemodynamic effects of the new hypotensive drug L 6150.
1976
Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
1973-11
Patents

Patents

Sample Use Guides

Oxdralazine was given orally in doses of 15 to 30 mg to 7 subjects with hypertension
Route of Administration: Oral
Name Type Language
OXDRALAZINE DIHYDROCHLORIDE
Common Name English
DL-150
Preferred Name English
L-6150
Code English
DL-150IT
Code English
ETHANOL, 2,2'-((6-HYDRAZINO-3-PYRIDAZINYL)IMINO)BIS-, HYDROCHLORIDE (1:2)
Systematic Name English
NSC-298268
Code English
Code System Code Type Description
CAS
27464-23-9
Created by admin on Mon Mar 31 21:52:43 GMT 2025 , Edited by admin on Mon Mar 31 21:52:43 GMT 2025
PRIMARY
PUBCHEM
168701
Created by admin on Mon Mar 31 21:52:43 GMT 2025 , Edited by admin on Mon Mar 31 21:52:43 GMT 2025
PRIMARY
EPA CompTox
DTXSID60181884
Created by admin on Mon Mar 31 21:52:43 GMT 2025 , Edited by admin on Mon Mar 31 21:52:43 GMT 2025
PRIMARY
FDA UNII
483KXL2L9D
Created by admin on Mon Mar 31 21:52:43 GMT 2025 , Edited by admin on Mon Mar 31 21:52:43 GMT 2025
PRIMARY
NSC
298268
Created by admin on Mon Mar 31 21:52:43 GMT 2025 , Edited by admin on Mon Mar 31 21:52:43 GMT 2025
PRIMARY